Donor Testing/Virology Laboratory

This laboratory (also known as the "Donor Testing Laboratory") employs a large, proficient staff of technical and support personnel for the preparation and testing of donor and non-donor blood. The testing procedures meet the requirements, regulations and guidelines of the Food and Drug Administration and the AABB (formally known as American Association of Blood Banks). The laboratory is licensed for virological testing by the State of Washington Department of Health (Medical Test Site/CLIA) and clinical laboratory testing by the State of California Department of Public Health. More than 440,000 samples are tested annually. In addition to routine ABO/RH typing of these samples, the lab routinely screens for red-cell antibodies, HBsAg, anti-HCV, anti-HBc, anti-HIV-1/-2, anti-HTLV-I/HTLV-II, anti-CMV, STS, and HCV/HIV/HBV/WNV nucleic acid by a technique known as NAT (Nucleic Acid Testing). Confirmatory testing is performed on samples with reactive HBsAg, anti-HCV, anti-HIV-1/-2 or anti-HTLV-I/HTLV-II results. Selected specimens are also tested by bacterial culturing.

The Donor Testing Laboratory is under the direction of Mark Destree MS, MBA, MT (ASCP), Director of the Blood Processing Laboratories. The Virology and Serology sections of the laboratory are managed by Gene Heresa MAED, MT (ASCP) SBB. The Virology section performs HBsAg, anti-HCV, anti-HBc, anti-HIV-1/-2, anti-HTLV-I/HTLV-II, anti-CMV, and Chagas testing. The Serology section performs ABO/RH typing, red cell antibody screening, and STS testing. The NAT and Special Studies sections of the laboratory are managed by Carol Taylor, PhD, MT(ASCP). The NAT section tests for HCV, HIV-1, HIV-2, HBV, and WNV. The Special Studies section oversees the performance of confirmatory testing, bacterial testing, and FDA approved donor reentry programs.

The Donor Testing Laboratory is equipped with state-of-the-art equipment and utilizes the most recent, accurate, FDA-approved test materials available for testing. In our commitment to excellence and to assure a safe and dependable blood supply to the region, the laboratory consistently implements newly developed tests upon availability. All sections of the laboratory evaluate new test methodologies and participate in clinical trials in cooperation with biotechnology and diagnostic reagent companies.

Our quality assurance program encompasses: the development and maintenance of written procedures; training, continuing education and competency evaluation of staff; participation in proficiency testing programs; validation of software, hardware, equipment and procedures; and the analysis of errors and outcomes of routine audits and practices.


Donor Testing / Virology
Lab Quick Links